September 17, 2021
“More than 60 cryptocurrency exchanges in South Korea must notify customers of a partial or full suspension of trading by Friday midnight, a week before a new regulation comes into effect. To continue operating, exchanges must register with the Financial… Continue Reading…
August 25, 2021
“Six of the world’s ten largest consumers of coal are in the Asia Pacific region. All of last year’s top consumers saw a decline in coal consumption from 2019, with the exception of China and Vietnam. Below were the world’s… Continue Reading…
July 19, 2021
“Ambrx Biopharma (AMAM)… This new biopharma stock has a Strong Buy rating from the analyst consensus, based on 3 positive reviews so far. The shares are priced at $19.56 and their $39.50 average target suggests room for an upside of 101%… Continue Reading…
June 14, 2021
“Shares of iTeos Therapeutics Inc. ITOS, 30.79% soared 58.5% in premarket trading on Monday after the company announced a deal with GlaxoSmithKline GSK, +0.39% to develop and commercialize an experimental cancer therapy. GSK will make a $625 million upfront payment to iTeos, with an additional $1.4… Continue Reading…
April 29, 2021
“Compass, Inc. (COMP)… After less than month in the public markets, Compass has already picked up 9 analyst reviews. These break down to 5 Buys and 4 Holds, giving the stock a Moderate Buy analyst consensus rating. The average price… Continue Reading…
November 2, 2020
“Alliance Data Systems (ADS)… Overall, ADS has a Strong Buy rating from the analyst consensus, based on 5 Buys and 1 Hold. The stock is selling for $53 and its $71.43 average price target implies an upside of ~35% over… Continue Reading…
October 28, 2020
“Chromadex (CDXC)… It’s not often that the analysts all agree on a stock, so when it does happen, take note. CDXC’s Strong Buy consensus rating is based on a unanimous 3 Buys. The stock’s $7.67 average price target suggests a… Continue Reading…
October 1, 2020
“PDC Energy (PDCE)… Are other analysts in agreement? They are. Only Buy ratings, 11, in fact, have been issued in the last three months. Therefore, the verdict is unanimous: PDCE is a Strong Buy. Given the $21.50 average price target,… Continue Reading…
September 3, 2020
“No one would have believed this even three months ago, but this may turn out to be the biggest year for IPOs since Alibaba went public in 2014. Already, 111 companies have raised $37.8 billion, according to Renaissance Capital. In 2014,… Continue Reading…
Recent Comments